{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:34:10Z","timestamp":1793147650248,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T00:00:00Z","timestamp":1531353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea","award":["1720030"],"award-info":[{"award-number":["1720030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00330-018-5608-7","type":"journal-article","created":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T13:28:49Z","timestamp":1531402129000},"page":"745-758","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis"],"prefix":"10.1007","volume":"29","author":[{"given":"Chong Hyun","family":"Suh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9477-7421","authenticated-orcid":false,"given":"Ho Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Chai","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choong Gon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,12]]},"reference":[{"key":"5608_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131:803\u2013820","journal-title":"Acta Neuropathol"},{"key":"5608_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00401-009-0561-9","volume":"118","author":"C Hartmann","year":"2009","unstructured":"Hartmann C, Meyer J, Balss J et al (2009) Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol 118:469\u2013474","journal-title":"Acta Neuropathol"},{"key":"5608_CR3","doi-asserted-by":"publisher","first-page":"16238","DOI":"10.1038\/srep16238","volume":"5","author":"P Kickingereder","year":"2015","unstructured":"Kickingereder P, Sahm F, Radbruch A et al (2015) IDH mutation status is associated with a distinct hypoxia\/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma. Sci Rep 5:16238","journal-title":"Sci Rep"},{"key":"5608_CR4","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"DJ Brat","year":"2015","unstructured":"Brat DJ, Verhaak RG, Aldape KD et al (2015) Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 372:2481\u20132498","journal-title":"N Engl J Med"},{"key":"5608_CR5","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","volume":"372","author":"JE Eckel-Passow","year":"2015","unstructured":"Eckel-Passow JE, Lachance DH, Molinaro AM et al (2015) Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 372:2499\u20132508","journal-title":"N Engl J Med"},{"key":"5608_CR6","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1002\/cncr.31039","volume":"123","author":"JJ Miller","year":"2017","unstructured":"Miller JJ, Shih HA, Andronesi OC, Cahill DP (2017) Isocitrate dehydrogenase-mutant glioma: evolving clinical and therapeutic implications. Cancer 123:4535\u20134546","journal-title":"Cancer"},{"key":"5608_CR7","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/neuonc\/now256","volume":"19","author":"H Zhou","year":"2017","unstructured":"Zhou H, Vallieres M, Bai HX et al (2017) MRI features predict survival and molecular markers in diffuse lower-grade gliomas. Neuro Oncol 19:862\u2013870","journal-title":"Neuro Oncol"},{"key":"5608_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/neuonc\/now121","volume":"19","author":"B Zhang","year":"2017","unstructured":"Zhang B, Chang K, Ramkissoon S et al (2017) Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas. Neuro Oncol 19:109\u2013117","journal-title":"Neuro Oncol"},{"key":"5608_CR9","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1007\/s00330-016-4653-3","volume":"27","author":"J Yu","year":"2017","unstructured":"Yu J, Shi Z, Lian Y et al (2017) Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma. Eur Radiol 27:3509\u20133522","journal-title":"Eur Radiol"},{"key":"5608_CR10","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3174\/ajnr.A5171","volume":"38","author":"Z Xing","year":"2017","unstructured":"Xing Z, Yang X, She D, Lin Y, Zhang Y, Cao D (2017) Noninvasive assessment of IDH mutational status in World Health Organization grade II and III astrocytomas using DWI and DSC-PWI combined with conventional MR imaging. AJNR Am J Neuroradiol 38:1134\u20131144","journal-title":"AJNR Am J Neuroradiol"},{"key":"5608_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3171\/2016.10.JNS161793","volume":"128","author":"A Tietze","year":"2018","unstructured":"Tietze A, Choi C, Mickey B et al (2018) Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting. J Neurosurg 128:391\u2013398","journal-title":"J Neurosurg"},{"key":"5608_CR12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/jmri.25358","volume":"45","author":"W Tan","year":"2017","unstructured":"Tan W, Xiong J, Huang W, Wu J, Zhan S, Geng D (2017) Noninvasively detecting Isocitrate dehydrogenase 1 gene status in astrocytoma by dynamic susceptibility contrast MRI. J Magn Reson Imaging 45:492\u2013499","journal-title":"J Magn Reson Imaging"},{"key":"5608_CR13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1148\/radiol.2016161422","volume":"283","author":"A Stadlbauer","year":"2017","unstructured":"Stadlbauer A, Zimmermann M, Kitzwogerer M et al (2017) MR Imaging-derived oxygen metabolism and neovascularization characterization for grading and IDH gene mutation detection of gliomas. Radiology 283:799\u2013809","journal-title":"Radiology"},{"key":"5608_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1148\/radiol.2016152679","volume":"283","author":"SJ Price","year":"2017","unstructured":"Price SJ, Allinson K, Liu H et al (2017) Less invasive phenotype found in isocitrate dehydrogenase-mutated glioblastomas than in isocitrate dehydrogenase wild-type glioblastomas: a diffusion-tensor imaging study. Radiology 283:215\u2013221","journal-title":"Radiology"},{"key":"5608_CR15","doi-asserted-by":"publisher","first-page":"6078","DOI":"10.1158\/1078-0432.CCR-17-0560","volume":"23","author":"SH Patel","year":"2017","unstructured":"Patel SH, Poisson LM, Brat DJ et al (2017) T2-FLAIR mismatch, an imaging biomarker for IDH and 1p\/19q status in lower-grade gliomas: a TCGA\/TCIA project. Clin Cancer Res 23:6078\u20136085","journal-title":"Clin Cancer Res"},{"key":"5608_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11060-016-2313-8","volume":"131","author":"S Nakae","year":"2017","unstructured":"Nakae S, Murayama K, Sasaki H et al (2017) Prediction of genetic subgroups in adult supra tentorial gliomas by pre- and intraoperative parameters. J Neurooncol 131:403\u2013412","journal-title":"J Neurooncol"},{"key":"5608_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11060-017-2506-9","volume":"134","author":"K Leu","year":"2017","unstructured":"Leu K, Ott GA, Lai A et al (2017) Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II\u2013III diffuse gliomas. J Neurooncol 134:177\u2013188","journal-title":"J Neurooncol"},{"key":"5608_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jocn.2017.01.007","volume":"39","author":"A Lasocki","year":"2017","unstructured":"Lasocki A, Tsui A, Gaillard F, Tacey M, Drummond K, Stuckey S (2017) Reliability of noncontrast-enhancing tumor as a biomarker of IDH1 mutation status in glioblastoma. J Clin Neurosci 39:170\u2013175","journal-title":"J Clin Neurosci"},{"key":"5608_CR19","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1002\/mrm.26820","volume":"78","author":"S Jiang","year":"2017","unstructured":"Jiang S, Zou T, Eberhart CG et al (2017) Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI. Magn Reson Med 78:1100\u20131109","journal-title":"Magn Reson Med"},{"key":"5608_CR20","first-page":"45888","volume":"8","author":"KL Hsieh","year":"2017","unstructured":"Hsieh KL, Chen CY, Lo CM (2017) Radiomic model for predicting mutations in the isocitrate dehydrogenase gene in glioblastomas. J Neurooncol 8:45888\u201345897","journal-title":"J Neurooncol"},{"key":"5608_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ejrad.2017.08.008","volume":"95","author":"JM Hempel","year":"2017","unstructured":"Hempel JM, Schittenhelm J, Brendle C et al (2017) Histogram analysis of diffusion kurtosis imaging estimates for in vivo assessment of 2016 WHO glioma grades: a cross-sectional observational study. Eur J Radiol 95:202\u2013211","journal-title":"Eur J Radiol"},{"key":"5608_CR22","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1007\/s00330-016-4451-y","volume":"27","author":"G Grabner","year":"2017","unstructured":"Grabner G, Kiesel B, Wohrer A et al (2017) Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational status. Eur Radiol 27:1556\u20131567","journal-title":"Eur Radiol"},{"key":"5608_CR23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11060-017-2613-7","volume":"135","author":"RL Delfanti","year":"2017","unstructured":"Delfanti RL, Piccioni DE, Handwerker J et al (2017) Imaging correlates for the 2016 update on WHO classification of grade II\/III gliomas: implications for IDH, 1p\/19q and ATRX status. J Neurooncol 135:601\u2013609","journal-title":"J Neurooncol"},{"key":"5608_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3174\/ajnr.A4491","volume":"37","author":"K Yamashita","year":"2016","unstructured":"Yamashita K, Hiwatashi A, Togao O et al (2016) MR imaging-based analysis of glioblastoma multiforme: estimation of IDH1 mutation status. AJNR Am J Neuroradiol 37:58\u201365","journal-title":"AJNR Am J Neuroradiol"},{"key":"5608_CR25","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s00330-015-4025-4","volume":"26","author":"J Xiong","year":"2016","unstructured":"Xiong J, Tan W, Wen J et al (2016) Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1\/2 mutations but not 1p\/19q genotyping in oligodendroglial tumours. Eur Radiol 26:1705\u20131715","journal-title":"Eur Radiol"},{"key":"5608_CR26","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/neuonc\/nov239","volume":"18","author":"K Wang","year":"2016","unstructured":"Wang K, Wang Y, Fan X et al (2016) Radiological features combined with IDH1 status for predicting the survival outcome of glioblastoma patients. Neuro Oncol 18:589\u2013597","journal-title":"Neuro Oncol"},{"key":"5608_CR27","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1200\/JCO.2016.67.1222","volume":"34","author":"C Choi","year":"2016","unstructured":"Choi C, Raisanen JM, Ganji SK et al (2016) Prospective longitudinal analysis of 2-hydroxyglutarate magnetic resonance spectroscopy identifies broad clinical utility for the management of patients with IDH-mutant glioma. J Clin Oncol 34:4030\u20134039","journal-title":"J Clin Oncol"},{"key":"5608_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3174\/ajnr.A4493","volume":"37","author":"A Biller","year":"2016","unstructured":"Biller A, Badde S, Nagel A et al (2016) Improved brain tumor classification by sodium mr imaging: prediction of IDH mutation status and tumor progression. AJNR Am J Neuroradiol 37:66\u201373","journal-title":"AJNR Am J Neuroradiol"},{"key":"5608_CR29","doi-asserted-by":"publisher","first-page":"e0123890","DOI":"10.1371\/journal.pone.0123890","volume":"10","author":"JK Wasserman","year":"2015","unstructured":"Wasserman JK, Nicholas G, Yaworski R et al (2015) Radiological and pathological features associated with IDH1-R132H mutation status and early mortality in newly diagnosed anaplastic astrocytic tumours. PLoS One 10:e0123890","journal-title":"PLoS One"},{"key":"5608_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10014-014-0211-3","volume":"32","author":"Y Sonoda","year":"2015","unstructured":"Sonoda Y, Shibahara I, Kawaguchi T et al (2015) Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas. Brain Tumor Pathol 32:99\u2013104","journal-title":"Brain Tumor Pathol"},{"key":"5608_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11060-014-1614-z","volume":"121","author":"S Lee","year":"2015","unstructured":"Lee S, Choi SH, Ryoo I et al (2015) Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1\/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging. J Neurooncol 121:141\u2013150","journal-title":"J Neurooncol"},{"key":"5608_CR32","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/neuonc\/not235","volume":"16","author":"G Reyes-Botero","year":"2014","unstructured":"Reyes-Botero G, Dehais C, Idbaih A et al (2014) Contrast enhancement in 1p\/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression. Neuro Oncol 16:662\u2013670","journal-title":"Neuro Oncol"},{"key":"5608_CR33","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3892\/ol.2014.2013","volume":"7","author":"S Qi","year":"2014","unstructured":"Qi S, Yu L, Li H et al (2014) Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms. Oncol Lett 7:1895\u20131902","journal-title":"Oncol Lett"},{"key":"5608_CR34","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3174\/ajnr.A2950","volume":"33","author":"JA Carrillo","year":"2012","unstructured":"Carrillo JA, Lai A, Nghiemphu PL et al (2012) Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma. AJNR Am J Neuroradiol 33:1349\u20131355","journal-title":"AJNR Am J Neuroradiol"},{"key":"5608_CR35","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nm.2682","volume":"18","author":"C Choi","year":"2012","unstructured":"Choi C, Ganji SK, DeBerardinis RJ et al (2012) 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nat Med 18:624\u2013629","journal-title":"Nat Med"},{"key":"5608_CR36","doi-asserted-by":"publisher","first-page":"5467","DOI":"10.1038\/s41598-017-05848-2","volume":"7","author":"Z Li","year":"2017","unstructured":"Li Z, Wang Y, Yu J, Guo Y, Cao W (2017) Deep Learning based Radiomics (DLR) and its usage in noninvasive IDH1 prediction for low grade glioma. Sci Rep 7:5467","journal-title":"Sci Rep"},{"key":"5608_CR37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/annonc\/mdw013","volume":"27","author":"L Dang","year":"2016","unstructured":"Dang L, Yen K, Attar EC (2016) IDH mutations in cancer and progress toward development of targeted therapeutics. Ann Oncol 27:599\u2013608","journal-title":"Ann Oncol"},{"key":"5608_CR38","doi-asserted-by":"publisher","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","volume":"151","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151:W65\u2013W94","journal-title":"Ann Intern Med"},{"key":"5608_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97\u2013109","journal-title":"Acta Neuropathol"},{"key":"5608_CR40","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529\u2013536","journal-title":"Ann Intern Med"},{"key":"5608_CR41","unstructured":"Higgins J, Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. http:\/\/ \n                    handbook.cochrane.org\n                    \n                  \/chapter_9\/9_5_2_ identifying_and_measuring_heterogeneity. htm. Updated March 2011. Accessed 2 October 2017"},{"key":"5608_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-2-9","volume":"2","author":"WL Deville","year":"2002","unstructured":"Deville WL, Buntinx F, Bouter LM et al (2002) Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2:9","journal-title":"BMC Med Res Methodol"},{"key":"5608_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3348\/kjr.2016.17.1.5","volume":"17","author":"CH Suh","year":"2016","unstructured":"Suh CH, Park SH (2016) Successful publication of systematic review and meta-analysis of studies evaluating diagnostic test accuracy. Korean J Radiol 17:5\u20136","journal-title":"Korean J Radiol"},{"key":"5608_CR44","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3348\/kjr.2015.16.6.1175","volume":"16","author":"KW Kim","year":"2015","unstructured":"Kim KW, Lee J, Choi SH, Huh J, Park SH (2015) Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers\u2014Part I. General guidance and tips. Korean J Radiol 16:1175\u20131187","journal-title":"Korean J Radiol"},{"key":"5608_CR45","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3348\/kjr.2015.16.6.1188","volume":"16","author":"J Lee","year":"2015","unstructured":"Lee J, Kim KW, Choi SH, Huh J, Park SH (2015) Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers\u2014Part II. Statistical methods of meta-analysis. Korean J Radiol 16:1188\u20131196","journal-title":"Korean J Radiol"},{"key":"5608_CR46","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","volume":"58","author":"JB Reitsma","year":"2005","unstructured":"Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58:982\u2013990","journal-title":"J Clin Epidemiol"},{"key":"5608_CR47","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1002\/sim.942","volume":"20","author":"CM Rutter","year":"2001","unstructured":"Rutter CM, Gatsonis CA (2001) A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 20:2865\u20132884","journal-title":"Stat Med"},{"key":"5608_CR48","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","volume":"58","author":"JJ Deeks","year":"2005","unstructured":"Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58:882\u2013893","journal-title":"J Clin Epidemiol"},{"key":"5608_CR49","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/neuonc\/nov307","volume":"18","author":"MI Fuente de la","year":"2016","unstructured":"de la Fuente MI, Young RJ, Rubel J et al (2016) Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma. Neuro Oncol 18:283\u2013290","journal-title":"Neuro Oncol"},{"key":"5608_CR50","unstructured":"Deeks JJ, Bossuyt PM, Gatsonis C (eds) 2013 Cochrane handbook for systematic reviews of diagnostic test accuracy version 1.0.0. The Cochrane Collaboration. \n                    http:\/\/srdta.cochrane.org\/handbook-dta-reviews\n                    \n                  . Accessed 9 Oct 2017"},{"issue":"Suppl 1","key":"5608_CR51","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1007\/s11606-012-2029-1","volume":"27","author":"TA Trikalinos","year":"2012","unstructured":"Trikalinos TA, Balion CM, Coleman CI et al (2012) Chapter 8: meta-analysis of test performance when there is a \u201cgold standard\u201d. J Gen Intern Med 27(Suppl 1):S56\u2013S66","journal-title":"J Gen Intern Med"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-018-5608-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-018-5608-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-018-5608-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T19:58:33Z","timestamp":1562875113000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-018-5608-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,12]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["5608"],"URL":"https:\/\/doi.org\/10.1007\/s00330-018-5608-7","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,12]]},"assertion":[{"value":"19 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Ho Sung Kim.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors (Chong Hyun Suh) has significant statistical expertise (4 years of experience in a systematic review and meta-analysis).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Institutional Review Board approval was not required because of the nature of our study, which was a systemic review and meta-analysis.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was not required for this study because of the nature of our study, which was a systemic review and meta-analysis.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"\u2022 A systemic review and meta-analysis performed at one institution.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}